Despite expression of oncogenic KRAS, premalignant pancreatic intraepithelial neoplasia 1 (PanIN1) lesions rarely become fully malignant pancreatic ductal adenocarcinoma (PDAC). The molecular mechanisms through which established risk factors, such as chronic pancreatitis, acinar cell damage, and/or defective autophagy increase the likelihood of PDAC development are poorly understood. We show that accumulation of the autophagy substrate p62/SQSTM1 in stressed KrasG12D acinar cells is associated with PDAC development and maintenance of malignancy in human cells and mice. p62 accumulation promotes neoplastic progression by controlling the NRF2-mediated induction of MDM2, which acts through p53-dependent and -independent mechanisms to abrogate checkpoints that prevent conversion of differentiated acinar cells to proliferative ductal progenitors. MDM2 targeting may be useful for preventing PDAC development in high-risk individuals.
Pubmed ID: 29153842 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Vector graphics software to create digital graphics, illustrations, and typography for several types of media: print, web, interactive, video, and mobile.
View all literature mentionsThis polyclonal targets MAFF, MAFK, MAFG
View all literature mentionsThis polyclonal targets H2AFX
View all literature mentionsThis polyclonal targets ALDH1A1 - Neuronal Marker
View all literature mentionsThis monoclonal targets detection of MDM2, MDM2 p60 cleavage product and p53-MDM2 complexes
View all literature mentionsThis monoclonal targets p53 (1C12) Mouse mAb
View all literature mentionsThis polyclonal targets CDKN1B
View all literature mentionsThis monoclonal targets α-Tubulin
View all literature mentionsThis monoclonal targets NQO1 (A-5)
View all literature mentionsThis monoclonal targets KEAP1 (D6B12) Rabbit mAb
View all literature mentionsThis polyclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis polyclonal targets Erk1/2
View all literature mentionsThis polyclonal targets CCND1
View all literature mentionsThis monoclonal targets PCNA
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets ATH 5 (MATH5)
View all literature mentionsThis monoclonal targets Cyclin D1
View all literature mentionsThis polyclonal targets HES1 (H-140)
View all literature mentionsThis monoclonal targets MDM2 (Ab-2) Human (Mouse)
View all literature mentionsThis polyclonal targets Sox-9 (H-90)
View all literature mentionsThis monoclonal targets Human NQO1
View all literature mentionsThis polyclonal targets p62
View all literature mentionsThis monoclonal targets IKK alpha
View all literature mentionsThis monoclonal targets Ki67 - Proliferation Marker
View all literature mentionsThis polyclonal targets Mouse KRT19
View all literature mentionsThis polyclonal targets alpha-Amylase antibody produced in rabbit
View all literature mentionsCell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line UN-KPC-960 is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsCell line UN-KC-6141 is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsCell line Capan-2 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line MIA PaCa-2 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions